Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. The company highlights having an unleveraged balance sheet, indicating no current debt burden. Emphasis is placed on capacity expansions funded through internal capex plans totaling INR1,100 crores from FY'24 to FY'28. Capex is planned for both Essentials (INR550 crores) and Specialties (incremental INR550 crores) segments. No references to raising funds externally were made; the company appears to rely on its strong balance sheet and operational cash flow to fund growth. The focus remains on doubling re

Any current/future capex/capital investment/strategic investment?

INR 1,100 crores capex planned between FY'24 to FY'28. Ambition to double revenues from FY'24, triple EBITDA, and double ROCE from 10% (FY'24) to 20% (FY'28). INR 550 crores capex in Essentials segment over FY'25 and FY'26 to expand and diversify product portfolio. INR 400 crores capex for Specialties from FY'25 to FY'26 and INR 150 crores from FY'26 to FY'28 for expanding and optimizing portfolio, including doubling Ketene and Diketene capacities at Dahej. Dahej facility civil foundation work started; revenues expected from FY'26 with peak in FY'28. Lote site has capacity for an additional IN

Future growth expectations in sales/revenue/volumes?

Laxmi Organic aims to double revenues from FY'24 to FY'28. Plans to triple EBITDA in the same period. Ambition to double ROCE from 10% in FY'24 to 20% in FY'28. Volume growth target of 1.75x from a base of 234 kt achieved in FY'24 for Essentials segment. Specialty segment to see growth with 20% of sales coming from products launched in the last 5 years. Dahej facility commercial revenues expected to start in FY'26 and peak by FY'28, doubling capacity for Ketene and Diketene products. Capex of INR1,100 crores planned from FY'24 to FY'28 to support growth. Expansion in market share

Future growth expectations in earnings/operating earnings/profits/EPS?

Laxmi Organic aims to double revenues and triple EBITDA from FY'24 to FY'28, as outlined by Rajan Venkatesh on the call (Page 14). The company targets doubling its ROCE from 10% in FY'24 to 20% by FY'28, reflecting strong profitability improvement ambitions (Page 14). Capex of INR1,100 crores planned between FY'24 to FY'28 to support this growth, including expanding capacity at Dahej and product portfolio (Pages 5, 14). Essentials segment aims to 1.75x volume growth and doubling revenue with margin upside potential from current bottom-cycle levels (Pages 5, 14). Specialties segment targets 20%

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Laxmi Organic Industries Limited. However, the company highlights a robust new business development pipeline, especially in specialties, with about 6 to 7 block fields available at the Lote site to accommodate up to INR500 crores of capex. They are confident of significant capacity expansions at Dahej to double capacities in Ketene and Diketene products. The management emphasizes strong demand and market share growth in their specialty portfolio, serving both domestic and global customers includ

Laxmi Organic Industries LtdQ1 FY25Chemicals & Petrochemicals

Laxmi Organic Industries Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹181P/E: 40.1Market Cap: ₹5.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Laxmi Organic aims to double revenues from FY'24 to FY'28.
Plans to triple EBITDA in the same period.
Ambition to double ROCE from 10% in FY'24 to 20% in FY'28.
Volume growth target of 1.75x from a base of 234 kt achieved in FY'24 for Essentials segment.
Specialty segment to see growth with 20% of sales coming from products launched in the last 5 years.
Dahej facility commercial revenues expected to start in FY'26 and peak by FY'28, doubling capacity for Ketene and Diketene products.
Capex of INR1,100 crores planned from FY'24 to FY'28 to support growth.
Expansion in market share, product portfolio, exports, and entry into new segments, especially fluoro in specialties.
Continued focus on operational excellence and cost leadership to propel growth.

Margin guidance

Category 3

Laxmi Organic aims to double revenues and triple EBITDA from FY'24 to FY'28, as outlined by Rajan Venkatesh on the call (Page 14).
The company targets doubling its ROCE from 10% in FY'24 to 20% by FY'28, reflecting strong profitability improvement ambitions (Page 14).
Capex of INR1,100 crores planned between FY'24 to FY'28 to support this growth, including expanding capacity at Dahej and product portfolio (Pages 5, 14).
Essentials segment aims to 1.75x volume growth and doubling revenue with margin upside potential from current bottom-cycle levels (Pages 5, 14).
Specialties segment targets 20% sales from new products launched in last five years, aiming for 2.5x EBITDA growth with cost leadership and portfolio expansion including fluoro segment (Pages 5, 12).
Management expresses confidence in sustained margin stability and growth driven by operational excellence and new product launches (Pages 12, 14).

See what Laxmi Organic Industries Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The transcript does not mention any current or planned fundraising through debt or equity.
The company highlights having an unleveraged balance sheet, indicating no current debt burden.
Emphasis is placed on capacity expansions funded through internal capex plans totaling INR1,100 crores from FY'24 to FY'28.
Capex is planned for both Essentials (INR550 crores) and Specialties (incremental INR550 crores) segments.
No references to raising funds externally were made; the company appears to rely on its strong balance sheet and operational cash flow to fund growth.
The focus remains on doubling revenues, tripling EBITDA, and doubling ROCE by FY'28 through internal resources and strategic capex rather than external fundraising.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Laxmi Organic Industries Limited.
However, the company highlights a robust new business development pipeline, especially in specialties, with about 6 to 7 block fields available at the Lote site to accommodate up to INR500 crores of capex.
They are confident of significant capacity expansions at Dahej to double capacities in Ketene and Diketene products.
The management emphasizes strong demand and market share growth in their specialty portfolio, serving both domestic and global customers including in China.
They expect to double revenues by FY'28 from FY'24 levels, with a capex pipeline of INR1,100 crores from FY'24 to FY'28 supporting this growth.
Overall, the company expresses strong confidence in market opportunities and growth potential, though specific order book figures are not disclosed.

See what Laxmi Organic Industries Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

INR 1,100 crores capex planned between FY'24 to FY'28.
Ambition to double revenues from FY'24, triple EBITDA, and double ROCE from 10% (FY'24) to 20% (FY'28).
INR 550 crores capex in Essentials segment over FY'25 and FY'26 to expand and diversify product portfolio.
INR 400 crores capex for Specialties from FY'25 to FY'26 and INR 150 crores from FY'26 to FY'28 for expanding and optimizing portfolio, including doubling Ketene and Diketene capacities at Dahej.
Dahej facility civil foundation work started; revenues expected from FY'26 with peak in FY'28.
Lote site has capacity for an additional INR 500 crores capex.
Focus on new products with 20% of specialty revenues from products launched in last 5 years.
Strategic investments in technology, bio-based products, and portfolio expansion especially in fluoro segment.

Track Laxmi Organic Industries Ltd — get its next earnings analysis in your feed

How does Laxmi Organic Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisLaxmi Organic Industries Ltd

Rev 2Mar 3

See where Laxmi Organic Industries Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Laxmi Organic Industries Ltd rank in Chemicals & Petrochemicals?

Compare Laxmi Organic Industries Ltd against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Laxmi Organic Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →